properdistatin

03/01/2015 - "In conclusion, properdistatin treatment inhibited angiogenesis and improved vascular function in A-07 tumors."
03/01/2015 - "The purpose of this study was to investigate the effect of properdistatin treatment on the morphology and function of tumor vasculature. "
11/22/2016 - "The tumors were grown in dorsal window chambers and were treated with 80 mg/kg/day properdistatin or vehicle. "
03/01/2015 - "Properdistatin-treated tumors showed reduced density of small-diameter vessels, reduced blood supply time, and increased plasma velocities. "
03/01/2015 - "Tumors were treated with 80 mg/kg/day properdistatin or vehicle for 4 days. "

11/22/2016 - "Properdistatin inhibits angiogenesis and improves vascular function in human melanoma xenografts with low thrombospondin-1 expression."
06/12/2017 - "The purpose of this study was to compare the effect of properdistatin and sunitinib treatment in a preclinical model of malignant melanoma. "
06/12/2017 - "R-18 human melanoma xenografts growing in dorsal window chambers were treated with properdistatin, sunitinib, or vehicle. "
03/01/2015 - "Thrombospondin-1 domain-containing peptide properdistatin improves vascular function in human melanoma xenografts."
06/12/2017 - "Properdistatin and sunitinib both inhibited angiogenesis, but had distinctly different effects on vascular morphology, vascular function, and extent of hypoxia in R-18 human melanoma xenografts."

12/01/2009 - "On the basis of the results from the in vitro screening, we have evaluated the ability of one peptide selected from each family named pentastatin-1, chemokinostatin-1, and properdistatin, respectively, to suppress angiogenesis in an MDA-MB-231 human breast cancer orthotopic xenograft model in severe combined immunodeficient mice. "

06/12/2017 - "Properdistatin and sunitinib both inhibited angiogenesis, but had distinctly different effects on vascular morphology, vascular function, and extent of hypoxia in R-18 human melanoma xenografts."